# Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria

> **NCT02372604** · PHASE3 · COMPLETED · sponsor: **Hospices Civils de Lyon** · enrollment: 15 (actual)

## Conditions studied

- Chronic Spontaneous Urticaria

## Interventions

- **DRUG:** Levocetirizine (as levocetirizine dihydrochloride), 5mg ( then 20 mg) per day . Oral administration.
- **DRUG:** Levocetirizine, (as levocetirizine dihydrochloride) 20 mg ( then 5 mg) per day. Oral administration.

## Key facts

- **NCT ID:** NCT02372604
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2018-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02372604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02372604, "Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous Urticaria". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02372604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*